Six years after suing pharmaceutical firms over the opioid epidemic, plaintiffs lawyers are gearing up to fight the manufacturer of Suboxone, a medication used to treat addiction to prescription painkillers.
Suboxone launched in 2002 as a tablet, but lawyers have filed lawsuits over a sublingual film version that the U.S. Food and Drug Administration approved in 2010. More than a dozen lawsuits say that British-based Indivior Inc. failed to warn that its Suboxone film, which dissolves on the tongue, causes severe dental health problems, such as cracking, erosion and tooth loss.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
